Saudi Journal of Gastroenterology

REVIEW ARTICLE
Year
: 2022  |  Volume : 28  |  Issue : 4  |  Page : 250--260

Methotrexate in inflammatory bowel disease: A primer for gastroenterologists


Turki AlAmeel1, Eman Al Sulais2, Tim Raine2 
1 Department of Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia
2 Division of Gastroenterology, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK

Correspondence Address:
Dr. Eman Al Sulais
Division of Gastroenterology, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0QQ
UK

Methotrexate is an antineoplastic agent that is also used at lower doses for anti-inflammatory properties. Along with thiopurines (azathioprine and 6-mercaptopurine), it has historically been an important part of pharmacological treatment for patients with inflammatory bowel disease. Despite an increase in therapeutic options, these immunomodulators continue to play important roles in the management of inflammatory bowel disease, used either as a monotherapy in mild to moderate cases or in combination with monoclonal antibodies to prevent immunogenicity and maintain efficacy. In light of data linking the use of thiopurines with the risk of malignancies, methotrexate has regained attention as a potential alternative. In this article, we review data on the pharmacology, safety, and efficacy of methotrexate and discuss options for the positioning of methotrexate alone, or in combination, in therapeutic algorithms for Crohn's disease and ulcerative colitis.


How to cite this article:
AlAmeel T, Al Sulais E, Raine T. Methotrexate in inflammatory bowel disease: A primer for gastroenterologists.Saudi J Gastroenterol 2022;28:250-260


How to cite this URL:
AlAmeel T, Al Sulais E, Raine T. Methotrexate in inflammatory bowel disease: A primer for gastroenterologists. Saudi J Gastroenterol [serial online] 2022 [cited 2022 Aug 15 ];28:250-260
Available from: https://www.saudijgastro.com/article.asp?issn=1319-3767;year=2022;volume=28;issue=4;spage=250;epage=260;aulast=AlAmeel;type=0